10x Genomics Inc (NAS:TXG)
$ 23.95 -0.88 (-3.54%) Market Cap: 2.87 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 3.99 GF Score: 75/100

10X Genomics Inc at Cowen Health Care Conference Transcript

Mar 06, 2023 / 04:10PM GMT
Release Date Price: $48.43 (-5.04%)
Daniel Gregory Brennan
TD Cowen, Research Division - Senior Tools & Diagnostics Analyst

I'm Brennan, obviously, day 1 of the TD Cowen Healthcare Conference, 43rd Annual. I'm pleased to be joined with me on stage, a senior management team of 10x Genomics. To my left, we have Serge Saxonov who is the CEO and to his left, we have Justin McAnear, who is the Chief Financial Officer. So first off, Serge and Justin welcome, and thank you for being here.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thanks. Glad to be here.

Justin J. McAnear
10x Genomics, Inc. - CFO

Thanks Glad to be here.

Questions & Answers

Daniel Gregory Brennan
TD Cowen, Research Division - Senior Tools & Diagnostics Analyst

Awesome. So kind of high-level kind of introductory question or 2 to kind of kick it off. 10x has grown revenues and an exceptional CAGR. If you go back over the last 5 years, north of 50%. Obviously, '22 was much lower year coming off a tough

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot